Higher dose of warfarin for patients with pulmonary embolism complicated by obstructive sleep apnea hypopnea syndrome

Heart and Lung: Journal of Acute and Critical Care

Volumn 43, Issue 4, 2014, Pages 358-362

  Jiang, Xie ^a   Yongxiang, Wei ^a   Wei, Zhang ^a   Xiangfeng, Zhang ^a   Jie, Li ^a   Achakzai, Rehmatullah ^a   Shuang, Liu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Obstructive sleep apnea hypopnea syndrome; Pulmonary embolism; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTACID AGENT; ANTIINFECTIVE AGENT; BIGUANIDE DERIVATIVE; CEPHALOSPORIN; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; MACROLIDE; PLASMINOGEN; QUINOLONE DERIVATIVE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME ACTIVITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERCOAGULABILITY; INTERNATIONAL NORMALIZED RATIO; LONGEST APNEA TIME; LONGEST HYPOPNEA TIME; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MALE; OXYGEN SATURATION; PARTIAL THROMBOPLASTIN TIME; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RESPIRATORY TRACT PARAMETERS; RISK FACTOR; SLEEP DISORDERED BREATHING;

OBSTRUCTIVE SLEEP APNEA HYPOPNEA SYNDROME; PULMONARY EMBOLISM; WARFARIN;

AGED; BODY WEIGHT; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; WARFARIN;

EID: 84903547375     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2014.04.005     Document Type: Article

References (33)

1. Punjabi N.M. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008, 5:136-143.
2. Konecny T., Kuniyoshi F.H., Orban M., et al. Under-diagnosis of sleep apnea in patients after acute myocardial infarction. JAm Coll Cardiol 2010, 56:742-743.
3. Zhang X.F., Gao Y.M., Zhu G.F., Yang J.H., Ding S.F., Liu S. Obstructive sleep apnea-hypopnea syndrome in patients with pulmonary thromboembolism: clinical features and management. Zhonghua Jie He He Hu Xi Za Zhi 2012, 35:180-183. [Article in Chinese].
4. Lévy P., Pépin J.L., Arnaud C., Baguet J.P., Dematteis M., Mach F. Obstructive sleep apnea and atherosclerosis. Prog Cardiovasc Dis 2009, 51:400-410.
5. Palma J.A., Urrestarazu E., Lopez-Azcarate J., et al. Increased sympathetic and decreased parasympathetic cardiac tone in patients with sleep related alveolar hypoventilation. Sleep 2013, 36:933-940.
6. Simiakakis M., Kapsimalis F., Chaligiannis E., Loukides S., Sitaras N., Alchanatis M. Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients. PLoS One 2012, 7:e39172.
7. Kritikou I., Basta M., Vgontzas A.N., et al. Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur Respir J 2014, 43:145-155.
8. Jelic S., Lederer D.J., Adams T., et al. Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea. Vasc Health Risk Manag 2009, 5:909-920.
9. Kezban O.S., Ali N.A., Umran T., et al. Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboembolism?. Chin Med J (Engl) 2012, 125:3712-3718.
10. Alonso-Fernández A., de la Peña M., Romero D., et al. Association between obstructive sleep apnea and pulmonary embolism. Mayo Clin Proc 2013, 88:579-587.
11. Epstein M.D., Segal L.N., Ibrahim S.M., Friedman N., Bustami R. Snoring and the risk of obstructive sleep apnea in patients with pulmonary embolism. Sleep 2010, 33:1069-1074.
12. Blokhin I.O., Lentz S.R. Mechanisms of thrombosis in obesity. Curr Opin Hematol 2013, 20:437-444.
13. Francis C.W. Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. NEngl J Med 2007, 356:1438-1444.
14. Lu Y., Yang J., Zhang H., Yang J. Prediction of warfarin maintenance dose in Han Chinese patients using a mechanistic model based on genetic and non-genetic factors. Clin Pharmacokinet 2013, 52:567-581.
15. Jie Li, Shuang Liu, jinghua Yang, Wei Guo, zengzhi Wang, shenghao Wang Randomized controlled study of the VKORC1 and CYP2C9 genotypes guiding the therapy for pulmonary thromboembolism with warfarin. Chin J Tuberc Respir Dis 2013, 36:950-953.
16. Choi J.B., Loredo J.S., Norman D., et al. Does obstructive sleep apnea increase hematocrit?. Sleep Breath 2006, 10:155-160.
17. Tazbirek M., Slowinska L., Skoczynski S., Pierzchala W. Short-term continuous positive airway pressure therapy reverses the pathological influence of obstructive sleep apnea on blood rheology parameters. Clin Hemorheol Microcirc 2009, 41:241-249.
18. Akinnusi M.E., Paasch L.L., Szarpa K.R., Wallace P.K., El Solh A.A. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. Respiration 2009, 77:25-31.
19. Iber C., Ancoli-Israel S., Chesson A.L., Quan S.F. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications 2007, American Academy of Sleep Medicine, Westchester, IL. 1st ed.
20. von Känel R., Natarajan L., Ancoli-Israel S., et al. Effect of continuous positive airway pressure on day/night rhythm of prothrombotic markers in obstructive sleep apnea. Sleep Med 2013, 14:58-65.
21. Kamali F., Khan T.I., King B.P., et al. Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin. Clin Pharmacol Ther 2004, 75:204-212.
22. Wallace J.L., Reaves A.B., Tolley E.A., et al. Comparison of initial warfarin response in obese patients versus non-obese patients. JThromb Thrombolysis 2013, 36:96-101.
23. Ruf W. Inflammation, obesity, and thrombosis. Blood 2013, 122:3415-3422.
24. Cushman M., Kuller L.H., Prentice R., et al. Estrogen plus progestin and risk of venous thrombosis. JAm Med Assoc 2004, 292:1573-1580.
25. Fitzpatrick M. Coagulability in obstructive sleep apnea. Can Respir J 2011, 18:338-348.
26. Lane S., Al-Zubiedi S., Hatch E., et al. The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors. Br J Clin Pharmacol 2012, 73:66-76.
27. Zade D., Beiser A., McGlinchey R., et al. Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure. JStroke Cerebrovasc Dis 2013, 22:119-125.
28. Thakre T.P., Mamtani M.R., Kulkarni H. Lack of association of the APOE epsilon 4 allele with the risk of obstructive sleep apnea: meta-analysis and meta-regression. Sleep 2009, 32:1507-1511.
29. Foley D.J., Masaki K., White L., Redline S. Relationship between apolipoprotein E epsilon4 and sleep-disordered breathing at different ages. JAm Med Assoc 2001, 286:1447-1448.
30. Kadotani H., Kadotani T., Young T., et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAm Med Assoc 2001, 285:2888-2890.
31. Zhu S., Wang Z., Wu X., Shu Y., Lu D. Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation. Lipids Health Dis 2014, 13:21.
32. Kimmel S.E., Christie J., Kealey C., et al. Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans. Pharmacogenomics J 2008, 8:53-60.
33. Won C.H., Chun H.J., Chandra S.M., Sarinas P.S., Chitkara R.K., Heidenreich P.A. Severe obstructive sleep apnea increases mortality in patients with ischemic heart disease and myocardial injury. Sleep Breath 2013, 17:85-91.